Abstract
ObjectivesChina suffers from high burdens of human papillomavirus (HPV) and cervical cancer, whereas the uptake of HPV vaccine remains low. The first Chinese domestic HPV vaccine was released in 2019....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have